Crossmark

The “SleepWell” intervention for patients with insomnia and persistent pain: a study protocol for a randomised waiting-list controlled trial of a cognitive behavioural group therapy programme

Crossref DOI link: https://doi.org/10.1186/s13063-025-09041-z

Published Online: 2025-08-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rosenvinge, Jan H.

Bergvik, Svein

Abeler, Karin

Tvedt, Kristin

Berge, Torkil

Lang, Nina

Wilhelmsen, Maja

Danielsson, Lena

Pettersen, Gunn

Friborg, Oddgeir https://orcid.org/0000-0001-6629-0782
Funding

Funding for this research was provided by:

The Regional Health Authorities of Northern Norway (HNF1715-24)

UiT The Arctic University of Norway
License Information

Text and Data Mining valid from 2025-08-27

Version of Record valid from 2025-08-27
More Information

Article History

Received: 21 December 2024

Accepted: 4 August 2025

First Online: 27 August 2025

Declarations

:

: The SleepWell study has been approved by the Regional Committee for Medical and Health Research Ethics (CaseID: 500457), the Center for Information Security and Privacy in Research (SIKT) and the Privacy Commissioner at the UiT—The Arctic University of Norway regarding Data Protection Impact Assessment (DPIA).

: Not applicable to the present study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below